News — Commit Biologics

News

Categories:

June 4 – 2025

Commit Biologics appoints leading industry experts to newly formed Scientific Advisory Board

News Research Technology

January 28 – 2025

Commit Biologics announces €5.5m seed financing extension investment by Korys to further develop its Bispecific Complement Engaging (BiCE™) platform

January 8 – 2025

Commit Biologics appoints accomplished R&D executive, Dr Janine Schuurman, to its Board of Directors

Employees Events

October 15 – 2024

Commit Biologics appoints Mikkel Wandahl Pedersen as Chief Scientific Officer

Employees Events

June 10 – 2024

Commit Biologics to present data on its Bispecific Complement Engaging (BiCE™) platform at the 16th International Conference on Complement Therapeutics

May 9 – 2024

Commit Biologics launches with €16m seed financing to pioneer complement system activation to treat cancer and autoimmune disease

February 14 – 2024

Commit Biologics receives Innobooster Grant from Innovation Fund Denmark

August 28 – 2023

Commit Biologics appoints Krishna Polu as Chief Executive Officer

June 28 – 2023

Publication describing the BiCE technology featured in Journal of Immunology

Publication Research Technology

February 8 – 2023

Anker Lundemose is appointed chairman of the board

Older Posts ›

For inquiries please contact us
at info@commitbio.com

Commit Biologics ApS
Universitetsbyen 83
8000 Aarhus C, Denmark

info@commitbio.com
LinkedIn

© 2025 Commit Biologics. All rights reserved.

CB_Brandmark_Light-Green